Jeremy Cetnar, MD – FDA 483, May 6, 2021

An FDA inspection of Jeremy Cetnar, MD, a clinical investigator in Portland, OR, identified a failure to maintain adequate and accurate case histories. This included not reporting adverse events in electronic case report forms and lacking essential MD review checklists for subject eligibility. These deficiencies indicate a significant lapse in adherence to clinical investigation protocols.